HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma
While chimeric antigen receptor (CAR)-T-cell therapy has demonstrated remarkable effectiveness in the treatment of B-cell lymphomas and leukemias, research on T-cell malignancies is still limited. Here, we reported a patient with hepatosplenic γδ T-cell lymphoma refractory to multiple lines of chemo...
Main Authors: | Xueer Xu, Cheng Zu, Mingming Zhang, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Huijun Xu, Jiazhen Cui, Jian Yu, Jimin Shi, Guoqing Wei, Alex H. Chang, He Huang, Yongxian Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/09636897231194265 |
Similar Items
-
New case of HIV cure: joined forces of haploidentical stem cells and HLA-mismatched cord blood
by: David Peterhoff
Published: (2023-06-01) -
Haploidentical transplantation has a superior graft-versus-leukemia effect than HLA-matched sibling transplantation for Ph– high-risk B-cell acute lymphoblastic leukemia
by: Menglin Fan, et al.
Published: (2022-04-01) -
Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma
by: Ruowen Wei, et al.
Published: (2023-05-01) -
Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum
by: Zachariah Chowdhury, et al.
Published: (2022-01-01) -
Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation
by: Xun-Hong Cao, et al.
Published: (2024-03-01)